Nimbus Synergies Appoints Jason Robertson as CEO to Lead Next Phase of Health Technology Growth
Nimbus Synergies, one of Canada’s leading early-stage health technology investors, announced a leadership transition to support the firm’s continued growth. Co-Founder and Managing Partner Jason Robertson has been appointed Chief Executive Officer, succeeding Paul Geyer, who will transition to the role of Chief Investment Officer (CIO).
This appointment marks a natural evolution in leadership, reflecting Jason’s pivotal contributions to Nimbus since its inception. As a Co-Founder and Managing Partner, Jason has been instrumental in shaping the firm’s vision, guiding strategy, sourcing high-impact deals, and supporting health tech entrepreneurs. Under his leadership, Nimbus has deployed over $35 million in capital and supported multiple successful exits across its portfolio.
“Nimbus was created with the vision to back exceptional founders and shape the future of healthcare,” said Jason Robertson. “It’s a privilege to step into the CEO role and continue building upon the extraordinary foundation Paul and our team have created. We’ve achieved so much together, and I’m grateful for the path paved before me. As we look ahead, I’m excited to carry this momentum forward and further scale our impact on Canada’s health technology ecosystem.”
Jason brings more than two decades of experience as a healthcare innovator, operator, and investor. He also mentors at LifeSciences BC, entrepreneurship@UBC, and Creative Destruction Labs.
Paul Geyer, who has served as Nimbus’s CEO since founding, has been instrumental in the firm’s transformation from an idea into a nationally recognized health tech investment platform. He oversaw the firm’s early investments, helped reimagine the Nimbus Generator startup hub, and fostered deep cross-sector collaborations between founders, funders, ecosystem partners, and healthcare stakeholders. As CIO, Paul will remain actively involved, providing strategic support to Nimbus across its investment activities and initiatives.
“Leading Nimbus has been one of the greatest honours of my career,” said Paul Geyer. “Together, we’ve grown Nimbus into a cornerstone of Canada’s healthcare innovation ecosystem. Jason has played an integral role in that journey — a trusted partner, visionary leader, and tireless advocate for entrepreneurs. I have every confidence in his leadership as he steps into the CEO role, and I look forward to continuing to support our portfolio and future investments as CIO.”
Adding perspective from the Board, Morgan Sturdy, Chair of Nimbus Synergies, commented: “This transition reflects the strength of Nimbus’s founding vision and the depth of talent within the firm. Jason has demonstrated exceptional leadership and insight, and with Paul’s focus on investment strategy, Nimbus is well-positioned to expand its impact in health innovation.”
About Nimbus Synergies
Nimbus Synergies is a $30M evergreen seed fund in Vancouver catalyzing Canadian health technology startups whose investees collectively generate more than $150 million in revenue annually and have impacted over 12 million lives worldwide. Nimbus invests in entrepreneurs using technology to improve health outcomes, increase efficiency, and reduce costs in healthcare. Nimbus is dedicated to shaping the future of healthcare innovation. For more information, please visit us at https://nimbusinc.vc/ or email us at info@nimbusinc.vc.
Original source here.